Venture
HistoSonics, Inc.
Latest Form D 2024-08-15- CIK 1479012
- State MI
- Other Health Care
- 9 Form D offerings since 2009-12-22
- Total sold
- $308M
- across 9 offerings
- Rounds
- 9
- Form D offerings since 2009-12-22
- Latest round
- $102M
- 2024-08-15 · 021-521642
- Investors
- 39
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2024-08-15 · $102M
- 2009-12-22$14.2M021-137110
- 2014-12-23$1.5M021-230769
- 2015-08-10$2.1M021-245375
- 2017-02-08$8.3M021-280309
- 2018-05-03$7M021-311564
- 2019-04-11$47.4M021-337133
- 2020-04-30$40.8M021-366063
- 2022-12-27$85M021-468711
- 2024-08-15$102M021-521642
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($102M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-521642 | First filed2024-08-15 | Latest2024-08-15 | Sought$102M | Sold$102M | Investors39 | Exemptions506(b) |
| 021-468711 | First filed2022-12-27 | Latest2022-12-27 | Sought$85M | Sold$85M | Investors38 | Exemptions506(b) |
| 021-366063 | First filed2020-04-30 | Latest2020-06-12 | Sought$40.8M | Sold$40.8M | Investors24 | Exemptions506(b) |
| 021-337133 | First filed2019-04-11 | Latest2019-04-11 | Sought$47.4M | Sold$47.4M | Investors44 | Exemptions506(b) |
| 021-311564 | First filed2018-05-03 | Latest2019-03-01 | Sought$7M | Sold$7M | Investors34 | Exemptions506(b) |
| 021-280309 | First filed2017-02-08 | Latest2017-02-08 | Sought$13.3M | Sold$8.3M | Investors13 | Exemptions506(b) |
| 021-245375 | First filed2015-08-10 | Latest2015-08-10 | Sought$3M | Sold$2.1M | Investors10 | Exemptions506(b) |
| 021-230769 | First filed2014-12-23 | Latest2014-12-23 | Sought$1.5M | Sold$1.5M | Investors8 | Exemptions506(b) |
| 021-137110 | First filed2009-12-22 | Latest2014-05-19 | Sought$14.2M | Sold$14.2M | Investors13 | Exemptions506(b) |
Who backs HistoSonics, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-08-15
| Name | Relationship |
|---|---|
| Michael Blue | RelationshipExecutive Officer, Director |
| Chris Dimitropoulos | RelationshipDirector |
| James Adox | RelationshipDirector |
| V. Kadir Kadhiresan | RelationshipDirector |
| Gerry Brunk | RelationshipDirector |
| Wen Chen | RelationshipDirector |
| Tom Tefft | RelationshipDirector |
| Fred Lee, Jr. | RelationshipDirector |
| Erica Rogers | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- Michigan (MI)
- Exemptions
- Rule 506(b)
- First filed
- 2009-12-22
- Latest filing
- 2024-08-15
Who backs HistoSonics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗